Subscribe to Newsletter


Another key player in the fight against COVID-19 celebrates a win. BioNTech was founded in 2008 to focus on cancer immunotherapy. Today, individualized immunotherapy remains the primary goal, despite the company rising to superstardom in the COVID-19 field with its collaboration with Pfizer on the Comirnaty vaccine. Even before the pandemic, the company was making a name for itself by working with other large pharma companies, including Eli Lilly, Sanofi, Genentech – mainly on mRNA-based research. In 2018, the company signed an agreement with Pfizer to develop mRNA-based vaccines for influenza. This early work would eventually pave the way for a COVID-19 vaccine. Pfizer and BioNTech announced a letter of intent to co-develop a COVID-19 vaccine on March 17, 2020 – with the work building on research from the influenza partnership.

And the rest is history.

The company recently announced its Q4 and full year financial results for 2021; total revenue exceeded 18.9 billion euro and net profit was around 10.3 billion euro.

Key facts

Global headquarters: Mainz, Germany

Number of Employees: 1300

Sales revenue in 2021: 18.9 billion euros

Other recent news

BioNTainer modular mRNA manufacturing solution launched to support scalable vaccine production in Africa

Company has expanded collaboration with Regeneron to advance its FixVac candidate BNT116 in combination with Libtayo (cemiplimab) for advanced non-small cell lung cancer

Research collaboration with Matinas BioPharma announced to evaluate novel delivery technology for mRNA vaccines

Three-year collaboration announced with Medigene to develop T-cell receptor based immunotherapies against cancer


 Honorable Mention: Moderna

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine